Quarterly report pursuant to Section 13 or 15(d)

Stockholders' Equity (Deficit) and Capitalization (Detail Textuals)

v3.20.2
Stockholders' Equity (Deficit) and Capitalization (Detail Textuals) - USD ($)
 1 Months Ended 9 Months Ended
Jul. 31, 2020
Sep. 30, 2020
Sep. 30, 2019
Equity [Line Items]      
Stock issuance costs   $ 0 $ 9,301
August 2020 Financing | Securities purchase agreement | Institutional investors and H.C. Wainwright & Co., LLC      
Equity [Line Items]      
Number of common stock units sold 56,333,334    
Number of pre-funded units sold 60,333,334    
Common units sold price per unit $ 0.06    
Pre-funded units sold price per unit $ 0.059    
Gross proceeds of units sold $ 6,939,667    
Warrants and rights outstanding term 5 years    
Stock issuance costs $ 854,078    
Proceeds from stock issuance $ 6,085,589    
August 2020 Financing | Securities purchase agreement | Institutional investors and H.C. Wainwright & Co., LLC | Placement agent      
Equity [Line Items]      
Warrant exercise price $ 0.075    
Warrants and rights outstanding term 5 years    
Warrants to purchase an aggregate shares of common stock 8,166,667    
Percentage of total shares of common stock and pre-funded warrants sold in offering 7.00%    
August 2020 Financing | Securities purchase agreement | Institutional investors and H.C. Wainwright & Co., LLC | Common Stock Warrants      
Equity [Line Items]      
Common stock and pre-funded stock units sold description each consisting of one share of common stock and one warrant to purchase one share of common stock    
Warrant exercise price $ 0.06    
August 2020 Financing | Securities purchase agreement | Institutional investors and H.C. Wainwright & Co., LLC | Pre-funded Warrants      
Equity [Line Items]      
Common stock and pre-funded stock units sold description each consisting of one pre-funded warrant to purchase one share of common stock and one warrant to purchase one share of common stock    
Warrant exercise price $ 0.001